Liraglutide and Renal Outcomes in Type 2 Diabetes: Results of the LEADER trial

被引：0
|
作者：
Mann, Johannes [1 ]
Nauck, Michael [2 ]
Jacob, Stephan [3 ]
Ludemann, Jorg
Brown-Frandsen, Kirstine
Rieck, Markus
Daniels, Gilbert H.
Kristensen, Peter
Nissen, Steven E.
Pocock, Stuart
Poulter, Neil R. [1 ]
Ravn, Lasse S.
Rasmussen, Soren
Steinberg, William M. [4 ]
Stockner, Mette
Zinman, Bernard [5 ]
Bergenstal, Richard M. [6 ]
Baeres, Florian M. M.
Marso, Steve P. [1 ]
Buse, John B. [1 ]
机构：
[1] Friedrich Alexander Univ Erlangen, Erlangen, Germany
[2] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[3] Praxis Pravent & Therapie, Villingen Schwenningen, Germany
[4] George Washington Univ, Med Ctr, Washington, DC 20052 USA
[5] Mt Sinai Hosp, New York, NY 10029 USA
[6] Int Diabet Ctr, St Louis Pk, MN USA
来源：
INTERNIST | 2017年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PS04
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [1] Liraglutide and renal outcomes in Type 2 diabetes: results of the 'Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results' (LEADER) trial
    Poulter, N.
    Mann, J. F. E.
    Brown-Frandsen, K.
    Daniels, G. H.
    Kristensen, P.
    Nauck, M. A.
    Nissen, S. E.
    Pocock, S.
    Buse, J. B.
    Petrie, J.
    [J]. DIABETIC MEDICINE, 2017, 34 : 23 - 24
  • [2] Liraglutide and Renal Outcomes in Type 2 Diabetes
    Mann, Johannes F. E.
    Orsted, David D.
    Brown-Frandsen, Kirstine
    Marso, Steven P.
    Poulter, Neil R.
    Rasmussen, Soren
    Tornoe, Karen
    Zinman, Bernard
    Buse, John B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09): : 839 - 848
  • [3] Liraglutide and Renal Outcomes in Type 2 Diabetes
    Imprialos, Konstantinos P.
    Stavropoulos, Konstantinos
    Doumas, Michael
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (22): : 2196 - 2196
  • [4] Liraglutide and Renal Outcomes in Type 2 Diabetes REPLY
    Mann, Johannes F. E.
    Orsted, David D.
    Buse, John B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (22): : 2197 - 2198
  • [5] Neoplasms Reported With Liraglutide or Placebo in People With Type 2 Diabetes: Results From the LEADER Randomized Trial
    Nauck, Michael A.
    Jensen, Thomas Jon
    Rosenkilde, Carina
    Calanna, Salvatore
    Buse, John B.
    [J]. DIABETES CARE, 2018, 41 (08) : 1663 - 1671
  • [6] Effects of liraglutide on cardiovascular events in patients with type 2 diabetes and polyvascular disease: results of the LEADER trial
    Zinman, B.
    Verma, S.
    Bhatt, D. L.
    Bain, S. C.
    Mann, J.
    Nauck, M. A.
    Pratley, R. E.
    Michelsen, M. M.
    Fries, T. Monk
    Rasmussen, S.
    Leiter, L. A.
    [J]. DIABETOLOGIA, 2018, 61 : S555 - S556
  • [7] Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease Results of the LEADER Trial
    Verma, Subodh
    Bhatt, Deepak L.
    Bain, Stephen C.
    Buse, John B.
    Mann, Johannes F. E.
    Marso, Steven P.
    Nauck, Michael A.
    Poulter, Neil R.
    Pratley, Richard E.
    Zinman, Bernard
    Michelsen, Marie M.
    Fries, Tea Monk
    Rasmussen, Soren
    Leiter, Lawrence A.
    [J]. CIRCULATION, 2018, 137 (20) : 2179 - 2183
  • [8] Liraglutide and semaglutide improve cardiovascular and renal outcomes across most BMI categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials
    Verma, S.
    Bain, S. C.
    Bhatt, D. L.
    Leiter, L. A.
    Mazer, C. D.
    McGuire, D. K.
    Pratley, R.
    Zinman, B.
    Lindberg, S.
    Rasmussen, S.
    Vrazic, H.
    Buse, J. B.
    [J]. DIABETOLOGIA, 2019, 62 : S560 - S560
  • [9] Liraglutide and Glycaemic Outcomes in the LEADER Trial
    Zinman, Bernard
    Nauck, Michael A.
    Bosch-Traberg, Heidrun
    Frimer-Larsen, Helle
    Orsted, David D.
    Buse, John B.
    [J]. DIABETES THERAPY, 2018, 9 (06) : 2383 - 2392
  • [10] Liraglutide and Glycaemic Outcomes in the LEADER Trial
    Bernard Zinman
    Michael A. Nauck
    Heidrun Bosch-Traberg
    Helle Frimer-Larsen
    David D. Ørsted
    John B. Buse
    [J]. Diabetes Therapy, 2018, 9 : 2383 - 2392
12345